Differential Effects of Enzyme Supplementation Therapy on Manifestations of Type 1 Gaucher Disease

This publication has 33 references indexed in Scilit:

• Individualised low-dose alglucerase therapy for type 1 Gaucher's disease
  The Lancet, 1995
• Low-dose enzyme replacement therapy for Gaucher's disease: Effects of age, sex, genotype, and clinical features on response to treatment
  The American Journal of Medicine, 1994
• Low‐dose high‐frequency enzyme replacement therapy for very young children with severe Gaucher disease
  British Journal of Haematology, 1993
• A Less Costly Regimen of Alglucerase to Treat Gaucher's Disease
  New England Journal of Medicine, 1992
• Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1991
• Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's Disease
  New England Journal of Medicine, 1991
• Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.
  Proceedings of the National Academy of Sciences, 1990
• Resting energy expenditure in Gaucher's disease type 1: Effect of Gaucher's cell burden on energy requirements
  Metabolism, 1989
• beta-Glucosidase assays in the diagnosis of Gaucher's disease.
  Clinical Chemistry, 1982
• Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1981